Markets

Latest News

Markets & Economy

Svalbard: The Arctic Flashpoint Igniting Global Tensions

While global attention remains fixed on Greenland and President Trump’s attempts to acquire it, a different Arctic territory may pose a more immediate risk for international conflict. Svalbard, an archipelago near Greenland, represents a unique flashpoint that could spark tensions not between the United States and Denmark, but between

Technology

Beyond Humanity: The Rise of Superintelligent AI and the Threat to Our Existence

The transformative power of artificial intelligence represents a shift more profound than the internet revolution itself. Just as the internet fundamentally altered human civilization, AI now stands poised to overshadow that digital transformation by several orders of magnitude. This isn’t merely technological evolution—it’s a complete restructuring of

World & Politics

U.S. Taxpayer-Funded Research Paves the Way for Chinese Military Advancements: A National Security Crisis

A recently published study has revealed that defense research facilities controlled by the Chinese government have received access to approximately $1 billion worth of American federally-funded research initiatives, creating what experts describe as serious national security vulnerabilities for the United States. The Center for Research Security and Integrity released

Technology

The Triumph of Technology: Unveiling the Spiritual Void in Bacon’s New Atlantis

Francis Bacon’s seventeenth-century manuscript “New Atlantis” serves as the foundation for a compelling analysis by technology investor Peter Thiel and researcher Sam Wolfe in their widely-circulated First Things essay. The piece examines how contemporary society’s embrace of boundless scientific advancement has fundamentally altered traditional religious conceptions

Big Pharma Has Spent $8 Billion on Targeted Radiation. Alpha Tau Is Building for the Tumors They Can’t Reach
Wall Street Wire

Big Pharma Has Spent $8 Billion on Targeted Radiation. Alpha Tau Is Building for the Tumors They Can’t Reach

TL;DR: Alpha Tau Medical Ltd. (NASDAQ: DRTS) is developing Alpha DaRT, a localized alpha-radiation therapy for solid tumors. Since late 2023, pharmaceutical giants have spent nearly $8 billion acquiring systemic radiopharmaceutical platforms that deliver radioactive payloads through the bloodstream. These work well for metastatic cancers but have limitations